Search Results
News in 2019
Viewing Page 1 of 2 | Showing Results 1 - 10 of 15
← Previous
1
2
Next →
May 20 , 2019
Read More
Jefferson Receives $3.1 Million from the Wyss Foundation for New Wellness Clinic
The new wellness clinic in South Philadelphia’s Bok Building is designed to serve the immigrant and refugee communities.Read More
May 20 , 2019
Read More
Thomas Jefferson University & Philadelphia Collaborative for Health Equity Announce Results of Latino Community Health Needs Assessment
Jefferson and the Philadelphia Collaborative for Health Equity also announced Thursday that they are awarding more than $500,000 in grants to organizations focused on closing the health disparity gap in North Philadelphia.Read More
May 20 , 2019
Read More
Mindfulness Helps Mothers with Opioid Use Disorder Combat Depression
Researchers found that mindfulness-based parenting interventions could help mothers in treatment for opioid use disorder.Read More
May 09 , 2019
Read More
Jefferson and Wills Eye Launch World’s First Center Focused on Connections Between the Eye and the Brain
First-of-its-Kind Center Holds Hope for Novel Treatments and Diagnoses of Neurological DiseasesRead More
April 29 , 2019
Read More
Catalyst Gift from Australian Philanthropist Barry Lambert to Support Innovation at Jefferson
Australian philanthropists Joy and Barry Lambert have made a $2 million gift to Thomas Jefferson University to advance innovative, sustainable medical solutions for industrial hemp and its derivatives.Read More
April 25 , 2019
Read More
Novel Vaccine for Colon Cancer Shows Positive Phase I Results
If it proves effective in larger-scale trials, the vaccine could train a patient's immune system to attack colon cancer spread prior to surgery.Read More
April 02 , 2019
Read More
Searching for Better Treatments for Irritated Tendons
New research on the biology of tendon irritation from Jefferson (Philadelphia University + Thomas Jefferson University) pinpoints key molecular components of injury, opening the possibility of targeting the pathways with pharmaceutical and other interventions.Read More
April 01 , 2019
Read More
New Glioblastoma Vaccine Shows Promising Results in Phase Ib Clinical Trial
Results from a phase 1b clinical trial of a new experimental brain cancer vaccine developed by Jefferson and Imvax, show the treatment was tolerated well by patients, slowed tumor recurrence, and prolonged patient survival.Read More
March 12 , 2019
Read More
How to Reduce Implicit Bias in Emergency Medical Care
Jefferson collaborated with researchers at the University of Pennsylvania on a training program for emergency medicine residents and tested how well it worked.Read More
March 07 , 2019
Read More
Potential Treatment for Cancer in Butterfly Disease
An international team of scientists have identified a potential drug treatment for patients with epidermolysis bullosa, or butterfly disease.Read More